Ming Yuan

Prof. Ming Yuan


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 March 2020 in International Journal of Molecular Medicine
Verified
Journal Article
Open access
PDF file
BWBin Wu
Bin Wu
HSHaixu Song
Haixu Song
MFMiaomiao Fan
Miaomiao Fan
FYFei You
Fei You
LZLiang Zhang
Liang Zhang
MYMing Yuan
Ming Yuan
Sepsis‑induced cardiomyopathy (SIC) is a complication of severe sepsis and septic shock characterized by an invertible myocardial depression. This study sought to explore the potential effects and mechanism of luteolin, a flavonoid polyphenolic compound, in lipopolysaccharide (LPS)‑induced myocardial injury. Experimental mice were randomly allocated into 3 groups (25 mice in each group): The control group (NC), the LPS group (LPS) and the LPS + luteolin group (LPS + Lut). Before the SIC model was induced, luteolin was dissolved in DMSO and injected intraperitoneally for 10 days into LPS + Lut group mice. NC group and LPS group mice received an equal volume of DMSO for 10 days. On day 11, the animal model of sepsis‑induced cardiac dysfunction was induced by intraperitoneal injection of LPS. A total of 12 h after LPS injection, measurements and comparisons were made among the groups. Luteolin administration improved cardiac function, attenuated the inflammatory response, alleviated mitochondrial injury, decreased oxidative stress, inhibited cardiac apoptosis and enhanced autophagy. In addition, luteolin significantly decreased the phosphorylation of AMP‑activated protein kinase (AMPK) in septic heart tissue. The protective effect of luteolin was abolished by 3‑methyladenine (an autophagy inhibitor) and dorsomorphin (compound C, an AMPK inhibitor), as evidenced by decreased autophagic activity, destabilized mitochondrial membrane potential and increased apoptosis in LPS‑treated cardiomyocytes, but was mimicked by 5‑aminoimidazole‑4‑carboxamide ribonucleotide (an AMPK activator), suggesting that luteolin attenuates LPS‑induced myocardial injury by increasing autophagy through AMPK activation. Luteolin may be a promising therapeutic agent for treating SIC.

1 January 2017 in BioMed Research International
Verified
Journal Article
Open access
PDF file
BWBin Wu
Bin Wu
JLJie Lin
Jie Lin
JLJian Luo
Jian Luo
DHDong Han
Dong Han
MFMiaomiao Fan
Miaomiao Fan
FYFu Yi
Fu Yi
Diabetic cardiomyopathy (DCM) is an important cause of heart failure in diabetic patients. The present study sought to explore the potential effects of dihydromyricetin (DHM) on DCM and its possible mechanism. A diabetic model was induced by intraperitoneal injection of streptozotocin (STZ) in C57BL/6J mice. Two weeks after the STZ injection, mice were randomly allocated into the following 4 groups for treatment: the control group (CON), the control treated with DHM group (CON + DHM), the diabetes group (DM), and the diabetes treated with DHM group (DM + DHM). DHM was dissolved in distilled water and administered daily by gavage. For 14 weeks, the CON + DHM group and DM + DHM group were given a dose of 100 mg/kg/day DHM (Sigma-Aldrich), while the CON and DM groups were intragastrically given equivalent volumes of distilled water. Assessments and comparisons were made among the groups based on cardiac function and structural changes, inflammation factors, markers of oxidative stress, mitochondria function, apoptosis, and autophagy. The DHM treatment normalized body weight, preserved cardiac function, attenuated oxidative stress (MDA, SOD, and GSH-Px), reduced the levels of inflammation factors (IL-6, TNF-α), alleviated pathological changes, improved mitochondrial function (ATP content, CS activity, and complex Ι/ΙΙ/ΙΙΙ/ΙV/V activities), inhibited cardiac apoptosis, and restored autophagy in diabetic mice. DHM may have a great therapeutic potential in the treatment of DCM.

1 June 2019 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
LZLiwei Zhang
Liwei Zhang
MYMing Yuan
Ming Yuan
LZLiang Zhang
Liang Zhang
BWBin Wu
Bin Wu
XSXiao Sun
Xiao Sun

20 February 2024 in Life Sciences
Verified
Journal Article
Closed access
QLQi Lu
Qi Lu
XQXing Qin
Xing Qin
CCChu Chen
Chu Chen
WYWei Yu
Wei Yu
JLJie Lin
Jie Lin
JRJun Ren
Jun Ren

7 November 2015 in Expert Opinion on Pharmacotherapy
Verified
Journal Article
Closed access
LLLi-Peng Liu
Li-Peng Liu
YWYan Wang
Yan Wang
RSRui Si
Rui Si
MYMing Yuan
Ming Yuan
KCKang Cheng
Kang Cheng
WGWen-Yi Guo
Wen-Yi Guo
Objectives: Controversy has been prompted based on drug interaction between proton pump inhibitors (PPIs) and aspirin/clopidogrel leading to weakened effects. However, whether such interaction was ...

27 July 2010 in Clinical and Experimental Pharmacology and Physiology
Verified
Journal Article
Closed access
PDF file
MYMing Yuan
Ming Yuan
MOMitsuru Ohishi
Mitsuru Ohishi
LWLin Wang
Lin Wang
HRHiromi Raguki
Hiromi Raguki
HWHaichang Wang
Haichang Wang
JRJun Ren
Jun Ren